|
1
|
Chen D, He J, Lu C, Zhou J, Fang K, Liu X
and Xu L: Increased expression of T cell immunoglobulin and mucin
domain 4 is positively associated with the disease severity of
patients with ankylosing spondylitis. Inflammation. 38:935–940.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akkoc N and Khan MA: Overestimation of the
prevalence of ankylosing spondylitis in the Berlin study: Comment
on the article by Braun et al. Arthritis Rheum.
52:4048–4050. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng SC, Liao Z, Yu DT, Chan ES, Zhao L and
Gu J: Epidemiology of spondyloarthritis in the People's Republic of
China: Review of the literature and commentary. Semin Arthritis
Rheum. 37:39–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taurog JD, Chhabra A and Colbert RA:
Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med.
374:2563–2574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sari I, Öztürk MA and Akkoc N: Treatment
of ankylosing spondylitis. Turk J Med Sci. 45:416–430. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martins NA, Furtado GE, Campos MJ, Leitão
JC, Filaire E and Ferreira JP: Exercise and ankylosing spondylitis
with New York modified criteria: A systematic review of controlled
trials with meta-analysis. Acta Reumatol Port. 39:298–308.
2014.PubMed/NCBI
|
|
7
|
Mau W, Zeidler H, Mau R, Majewski A,
Freyschmidt J, Stangel W and Deicher H: Clinical features and
prognosis of patients with possible ankylosing spondylitis. Results
of a 10-year followup. J Rheumatol. 15:1109–1114. 1988.PubMed/NCBI
|
|
8
|
Husseinzadeh N and Davenport SM: Role of
toll-like receptors in cervical, endometrial and ovarian cancers: A
review. Gynecol Oncol. 135:359–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim KH and Staudt LM: Toll-like receptor
signaling. Cold Spring Harb Perspect Biol. 5:a0112472013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huggins T, Haught JC, Xie S, Tansky CS,
Klukowska M, Miner MC and White DJ: Quantitation of endotoxin and
lipoteichoic acid virulence using toll receptor reporter gene. Am J
Dent. 29:321–327. 2016.PubMed/NCBI
|
|
11
|
Shimizu M: Multifunctions of dietary
polyphenols in the regulation of intestinal inflammation. J Food
Drug Anal. 25:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abhyankar MM, Orr MT, Lin S, Suraju MO,
Simpson A, Blust M, Pham T, Guderian JA, Tomai MA, Elvecrog J, et
al: Adjuvant composition and delivery route shape immune response
quality and protective efficacy of a recombinant vaccine for
entamoeba histolytica. NPJ Vaccines. 3:222018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takakubo Y, Barreto G, Konttinen YT, Oki H
and Takagi M: Role of innate immune sensors, TLRs, and NALP3 in
rheumatoid arthritis and osteoarthritis. J Long Term Eff Med
Implants. 24:243–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zauner D, Quehenberger F, Hermann J,
Dejaco C, Stradner MH, Stojakovic T, Angerer H, Rinner B and
Graninger WB: Whole body hyperthermia treatment increases
interleukin 10 and toll-like receptor 4 expression in patients with
ankylosing spondylitis: A pilot study. Int J Hyperthermia.
30:393–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gómez R, Castro A, Martínez J,
Rodríguez-García V, Burgués O, Tarín JJ and Cano A: Receptor
activator of nuclear factor Kappa B (RANK) and clinicopathological
variables in endometrial cancer: A study at protein and gene level.
Int J Mol Sci. 19(pii): E18482018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang JH, Lee E, Lee B, Cho WK, Ma JY and
Park KI: Ethanolic extracts of Artemisia apiacea hance
improved atopic dermatitis-like skin lesions in vivo and suppressed
TNF-alpha/IFN-gamma(−)induced proinflammatory chemokine production
in vitro. Nutrients. 10(pii): E8062018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang L, Liu J, Wan L, Zhu F, Tan B and
Zhang P: Xinfeng capsule improves hypercoagulative state by
inhibiting miR-155/NF-κB signaling pathway in patients with active
ankylosing spondylitis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
32:1094–1098. 2016.(In Chinese). PubMed/NCBI
|
|
19
|
Noort AR, Tak PP and Tas SW: Non-canonical
NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Arthritis Res Ther. 17:152015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shostak K and Chariot A: EGFR and NF-κB:
Partners in cancer. Trends Mol Med. 21:385–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Misra RS, Bhattacharya S, Huyck HL, Wang
JC, Slaunwhite CG, Slaunwhite SL, Wightman TR, Secor-Socha S, Misra
SK, Bushnell TP, et al: Flow-based sorting of neonatal lymphocyte
populations for transcriptomics analysis. J Immunol Methods.
437:13–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muller GW, Chen R, Huang SY, Corral LG,
Wong LM, Patterson RT, Chen Y, Kaplan G and Stirling DI: Amino-
substituted thalidomide analogs: Potent inhibitors of TNF-alpha
production. Bioorg Med Chem Lett. 9:1625–1630. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoy SM: Pomalidomide: A review in relapsed
and refractory multiple myeloma. Drugs. 77:1897–1908. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang YT, Cheng CC, Chiu TH and Lai PC:
Therapeutic potential of thalidomide for gemcitabine-resistant
bladder cancer. Int J Oncol. 47:1711–1124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rezaiemanesh A, Abdolmaleki M,
Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, Soleimanifar N,
Zavvar M and Nicknam MH: Immune cells involved in the pathogenesis
of ankylosing spondylitis. Biomed Pharmacother. 100:198–204. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nicoletti F, Zaccone P, Di Marco R,
Lunetta M, Magro G, Grasso S, Meroni P and Garotta G: Prevention of
spontaneous autoimmune diabetes in diabetes-prone BB rats by
prophylactic treatment with antirat interferon-gamma antibody.
Endocrinology. 138:281–288. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zaky DS and El-Nahrery EM: Role of
interleukin-23 as a biomarker in rheumatoid arthritis patients and
its correlation with disease activity. Int Immunopharmacol.
31:105–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El-Wakkad A, Hassan Nel M, Sibaii H and
El-Zayat SR: Proinflammatory, anti-inflammatory cytokines and
adiponkines in students with central obesity. Cytokine. 61:682–687.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Urushima H, Nishimura J, Mizushima T,
Hayashi N, Maeda K and Ito T: Perilla frutescens extract
ameliorates DSS-induced colitis by suppressing proinflammatory
cytokines and inducing anti-inflammatory cytokines. Am J Physiol
Gastrointest Liver Physiol. 308:G32–G41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou C, Wu Q, Ouyang C and Huang T: Effects
of an intravitreal injection of interleukin-35-expressing plasmid
on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med.
38:713–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji X, Zhou P, Zhong L, Xu A, Tsang ACO and
Chan PKL: Smart surgical catheter for C-reactive protein sensing
based on an imperceptible organic transistor. Adv Sci (Weinh).
5:17010532018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, Potempa LA, El Kebir D and Filep JG:
C-reactive protein and inflammation: Conformational changes affect
function. Biol Chem. 396:1181–1197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Frasca D and Blomberg BB: Inflammaging
decreases adaptive and innate immune responses in mice and humans.
Biogerontology. 17:7–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rusman T, Ten Wolde S, Euser SM, van der
Ploeg T, van Hall O and van der Horst-Bruinsma IE: Gender
differences in retention rate of tumor necrosis factor alpha
inhibitor treatment in ankylosing spondylitis: A retrospective
cohort study in daily practice. Int J Rheum Dis. 21:836–842. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shang J, Zhang Y, Jiang Y, Li Z, Duan Y,
Wang L, Xiao J and Zhao Z: NOD2 promotes endothelial-to-mesenchymal
transition of glomerular endothelial cells via MEK/ERK signaling
pathway in diabetic nephropathy. Biochem Biophys Res Commun.
484:435–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lalancette-Hebert M, Faustino J,
Thammisetty SS, Chip S, Vexler ZS and Kriz J: Live imaging of the
innate immune response in neonates reveals differential TLR2
dependent activation patterns in sterile inflammation and
infection. Brain Behav Immun. 65:312–327. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Satoh T and Akira S: Toll-like receptor
signaling and its inducible proteins. Microbiol Spectr. Dec
4–2016.(Epub ahead of print). doi:
10.1128/microbiolspec.MCHD-0040-2016. PubMed/NCBI
|
|
40
|
Sugitharini V, Pavani K, Prema A and Berla
Thangam E: TLR-mediated inflammatory response to neonatal pathogens
and co-infection in neonatal immune cells. Cytokine. 69:211–217.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akira S, Takeda K and Kaisho T: Toll-like
receptors: Critical proteins linking innate and acquired immunity.
Nat Immunol. 2:675–680. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kragstrup TW, Andersen T, Holm C,
Schiøttz-Christensen B, Jurik AG, Hvid M and Deleuran B: Toll-like
receptor 2 and 4 induced interleukin-19 dampens immune reactions
and associates inversely with spondyloarthritis disease activity.
Clin Exp Immunol. 180:233–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Assassi S, Reveille JD, Arnett FC, Weisman
MH, Ward MM, Agarwal SK, Gourh P, Bhula J, Sharif R, Sampat K, et
al: Whole-blood gene expression profiling in ankylosing spondylitis
shows upregulation of Toll-like receptor 4 and 5. J Rheumatol.
38:87–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
De Rycke L, Vandooren B, Kruithof E, De
Keyser F, Veys EM and Baeten D: Tumor necrosis factor alpha
blockade treatment down-modulates the increased systemic and local
expression of toll-like receptor 2 and Toll-like receptor 4 in
spondylarthropathy. Arthritis Rheum. 52:2146–2158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fagone P, Muthumani K, Mangano K, Magro G,
Meroni PL, Kim JJ, Sardesai NY, Weiner DB and Nicoletti F: VGX-1027
modulates genes involved in lipopolysaccharide-induced Toll-like
receptor 4 activation and in a murine model of systemic lupus
erythematosus. Immunology. 142:594–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Stojanovic I, Cuzzocrea S, Mangano K,
Mazzon E, Miljkovic D, Wang M, Donia M, Al Abed Y, Kim J, Nicoletti
F, et al: In vitro, ex vivo and in vivo immunopharmacological
activities of the isoxazoline compound VGX-1027: Modulation of
cytokine synthesis and prevention of both organ-specific and
systemic autoimmune diseases in murine models. Clin Immunol.
123:11–323. 2007. View Article : Google Scholar
|
|
47
|
Younan P, Ramanathan P, Graber J, Gusovsky
F and Bukreyev A: The Toll-like receptor 4 antagonist eritoran
protects mice from lethal filovirus challenge. MBio. 8(pii):
e00226–17. 2017.PubMed/NCBI
|
|
48
|
Codreanu C, Šírová K, Jarosova K and
Batalov A: Assessment of effectiveness and safety of biosimilar
infliximab (CT-P13) in a real-life setting for treatment of
patients with active rheumatoid arthritis or ankylosing
spondylitis. Curr Med Res Opin. 34:1763–1769. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Osswald D, Rameau AC, Speeg-Schatz C,
Terzic J and Sauer A: Clinical and epidemiological profile of
pediatric uveitis, course of inflammatory uveitis treated with
anti-TNF alpha. J Fr Ophtalmol. 41:447–452. 2018.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Siljehult F, Ärlestig L, Eriksson C and
Rantapää-Dahlqvist S: Concentrations of infliximab and anti-drug
antibodies in relation to clinical response in patients with
rheumatoid arthritis. Scand J Rheumatol. 47:345–350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wasserman MJ, Weber DA, Guthrie JA, Bykerk
VP, Lee P and Keystone EC: Infusion-related reactions to infliximab
in patients with rheumatoid arthritis in a clinical practice
setting: Relationship to dose, antihistamine pretreatment, and
infusion number. J Rheumatol. 31:1912–1917. 2004.PubMed/NCBI
|
|
52
|
Kim BY and Kim HS: Phlegmonous gastritis
in an ankylosing spondylitis patient treated with infliximab.
Korean J Intern Med. 32:945–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Maksymowych WP: Ankylosing spondylitis.
Not just another pain in the back. Can Fam Physician. 50:257–262.
2004.PubMed/NCBI
|
|
54
|
Dong M, Yu D, Duraipandiyan V and Abdullah
Al-Dhabi N: The protective effect of chrysanthemum indicum extract
against ankylosing spondylitis in mouse models. Biomed Res Int.
2017:82062812017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Aletaha S, Haddad L, Roozbehkia M, Bigdeli
R, Asgary V, Mahmoudi M and Mirshafiey A: M2000 (β-D-Mannuronic
Acid) as a novel antagonist for blocking the TLR2 and TLR4
downstream signalling pathway. Scand J Immunol. 85:122–129. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Roozbehkia M, Mahmoudi M, Aletaha S,
Rezaei N, Fattahi MJ, Jafarnezhad-Ansariha F, Barati A and
Mirshafiey A: The potent suppressive effect of β-d-mannuronic acid
(M2000) on molecular expression of the TLR/NF-kB signaling pathway
in ankylosing spondylitis patients. Int Immunopharmacol.
52:191–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu GJ, Lin YW, Chuang CY, Tsai HC and Chen
RM: Liver nitrosation and inflammation in septic rats were
suppressed by propofol via downregulating TLR4/NF-κB-mediated iNOS
and IL-6 gene expressions. Life Sci. 195:25–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhao Y, Liu Z and Zhang H: Astragaloside
protects myocardial cells from apoptosis through suppression of the
TLR4/NF-κB signaling pathway. Exp Ther Med. 15:1505–1509.
2018.PubMed/NCBI
|
